1. Home
  2. RNP vs EVO Comparison

RNP vs EVO Comparison

Compare RNP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

N/A

Current Price

$20.88

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$2.86

Market Cap

934.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNP
EVO
Founded
2003
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNP
EVO
Price
$20.88
$2.86
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
75.6K
86.6K
Earning Date
01-01-0001
04-08-2026
Dividend Yield
7.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.27
$2.31
52 Week High
$22.99
$4.80

Technical Indicators

Market Signals
Indicator
RNP
EVO
Relative Strength Index (RSI) 46.44 46.65
Support Level $20.45 $2.63
Resistance Level $21.00 $3.78
Average True Range (ATR) 0.25 0.09
MACD -0.06 -0.03
Stochastic Oscillator 22.28 34.13

Price Performance

Historical Comparison
RNP
EVO

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: